Soru

Zorluk: KolayPulmonary and Critical Care

A 6262-year-old retired mechanic comes to the outpatient clinic with a 33-day history of progressively worsening dyspnea. He states that his daily morning cough has become more frequent and is now producing thick, dark yellow sputum in significantly greater amounts than usual. His medical history is significant for chronic obstructive pulmonary disease and hypertension. He previously smoked 22 packs of cigarettes daily for 2020 years before quitting 55 years ago. His temperature is 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}), pulse is 98/min98/\text{min}, respirations are 22/min22/\text{min}, and blood pressure is 135/85 mmHg135/85\text{ mmHg}. Pulse oximetry shows 93%93\% on ambient air. Pulmonary auscultation demonstrates a prolonged expiratory phase with diffuse bilateral wheezing. Cardiovascular examination is unremarkable with no jugular venous distention. There is no peripheral edema. Which of the following therapeutic interventions are indicated for this patient? (Select all that apply)

  1. Systemic administration of glucocorticoidsCevap
  2. Nebulized short-acting bronchodilator therapyCevap
  3. Prescription of an oral macrolide antibioticCevap
  4. D
    Intravenous administration of a loop diuretic
  5. E
    Intravenous administration of broad-spectrum antibiotics covering Pseudomonas aeruginosa

Cevap

The correct interventions are the systemic administration of glucocorticoids, nebulized short-acting bronchodilator therapy, and the prescription of an oral macrolide antibiotic.
The correct interventions form the standard-of-care bundle for managing an acute chronic obstructive pulmonary disease (COPD) exacerbation. This patient presents with the three classic cardinal symptoms: increased dyspnea, increased sputum volume, and increased sputum purulence. Management for this triad includes short-acting bronchodilators to acutely relieve bronchospasm, systemic glucocorticoids to decrease airway inflammation and improve recovery time, and oral antibiotics (such as a macrolide) to treat common bacterial triggers.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and vital signs.
The patient exhibits worsening dyspnea, increased sputum volume, and increased sputum purulence, without signs of fluid overload or hemodynamic instability.
Identifying the three cardinal symptoms confirms an acute COPD exacerbation that requires a specific treatment bundle.
2
Select interventions to immediately relieve airway obstruction and inflammation.
Short-acting bronchodilators and systemic glucocorticoids are chosen.
These therapies are the cornerstone of COPD exacerbation management to rapidly improve airflow and shorten the duration of the exacerbation.
3
Evaluate the indication and setting for antimicrobial therapy.
An oral macrolide is selected.
The presence of all three cardinal symptoms strongly suggests a bacterial trigger, warranting targeted, narrow-spectrum outpatient oral antibiotics rather than broad-spectrum intravenous agents.

Anahtar Kavram

The initial management of an acute COPD exacerbation with all three cardinal symptoms includes short-acting bronchodilators, systemic glucocorticoids, and targeted antibiotic therapy.
Bu soruyu puanla